Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
CALL
ProShares Ultra Financials
UYG
$841M
| $306K | ﹤0.01% |
5,700
-4,900
| -46% | -$244K |
|
4627
Home Bancorp
HBCP
$568M
| $305K | ﹤0.01% |
7,776
+3,710
| +91% | +$144K |
|
4628
CALL
Travel + Leisure Co
TNL
$4.72B
| $305K | ﹤0.01% |
5,900
+5,100
| +638% | +$244K |
|
4629
Artesian Resources
ARTNA
$352M
| $304K | ﹤0.01% |
8,159
+4,087
| +100% | +$151K |
|
4630
Ardmore Shipping
ASC
$712M
| $304K | ﹤0.01% |
33,663
+15,816
| +89% | +$132K |
|
|
CEPU
4631
Central Puerto
CEPU
$2.24B
| $304K | ﹤0.01% |
62,600
-19,267
| -24% | -$69.3K |
|
4632
CALL
Flowserve
FLS
$9.78B
| $304K | ﹤0.01% |
6,100
-3,800
| -38% | -$182K |
|
|
CBIO
4633
Crescent Biopharma
CBIO
$552M
| $304K | ﹤0.01% |
575
+172
| +43% | +$93.1K |
|
4634
PUT
Vicor
VICR
$9.85B
| $304K | ﹤0.01% |
6,500
-4,300
| -40% | -$164K |
|
|
ZEUS
4635
DELISTED
Olympic Steel
ZEUS
| $304K | ﹤0.01% |
17,025
+1,475
| +9% | +$23.4K |
|
|
GLUU
4636
CALL
DELISTED
Glu Mobile Inc.
GLUU
| $304K | ﹤0.01% |
50,200
-700
| -1% | -$4K |
|
4637
Rayonier Advanced Materials
RYAM
$608M
| $303K | ﹤0.01% |
79,062
-100,144
| -56% | -$409K |
|
4638
Southern Missouri Bancorp
SMBC
$867M
| $303K | ﹤0.01% |
7,904
+3,929
| +99% | +$145K |
|
4639
EverQuote
EVER
$852M
| $302K | ﹤0.01% |
8,790
+4,456
| +103% | +$124K |
|
4640
CALL
J.M. Smucker
SJM
$12.6B
| $302K | ﹤0.01% |
2,900
-8,800
| -75% | -$931K |
|
4641
Bristow Group
VTOL
$1.35B
| $302K | ﹤0.01% |
14,863
+2,414
| +19% | +$47.8K |
|
|
TUP
4642
PUT
DELISTED
Tupperware Brands Corporation
TUP
| $302K | ﹤0.01% |
35,200
+19,400
| +123% | +$212K |
|
4643
Limoneira
LMNR
$239M
| $301K | ﹤0.01% |
15,675
+7,964
| +103% | +$152K |
|
4644
Titan Machinery
TITN
$423M
| $301K | ﹤0.01% |
20,386
+7,947
| +64% | +$124K |
|
|
EBIX
4645
CALL
DELISTED
Ebix Inc
EBIX
| $301K | ﹤0.01% |
9,000
-1,700
| -16% | -$62.8K |
|
4646
Park-Ohio Holdings
PKOH
$581M
| $300K | ﹤0.01% |
8,887
+4,445
| +100% | +$140K |
|
4647
Titan International
TWI
$466M
| $300K | ﹤0.01% |
82,942
+17,236
| +26% | +$51.3K |
|
4648
CALL
ICICI Bank
IBN
$109B
| $299K | ﹤0.01% |
19,800
+13,500
| +214% | +$183K |
|
4649
Lifecore Biomedical
LFCR
$165M
| $299K | ﹤0.01% |
26,387
+13,873
| +111% | +$148K |
|
4650
CALL
United Therapeutics
UTHR
$21.9B
| $299K | ﹤0.01% |
3,400
-4,000
| -54% | -$352K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.